|
Market Closed -
Nasdaq
21:00:00 17/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 7.130 USD | -3.26% |
|
-0.42% | -60.74% |
| 11-06 | BofA Securities Adjusts Avalo Therapeutics Price target to $24 From $29 | MT |
| 11-05 | Wedbush Adjusts Price Target on Avalo Therapeutics to $20 From $22, Keeps Outperform Rating | MT |
Stock exchange
Nasdaq
AVTX 7.130 $
-3.26%
22.34M
$
Quotes 5-day view: Avalo Therapeutics, Inc.
Delayed Quote Nasdaq| 11/11/2026 | 12/11/2026 | 13/11/2026 | 16/11/2026 | 17/11/2026 | |
|---|---|---|---|---|---|
| Last | US$8.510 | US$7.700 | US$7.760 | US$7.370 | US$7.130 |
| Volume | 1,839,395 | 2,960,580 | 974,224 | 1,116,528 | 3,133,750 |
| Change | +18.85% | -9.52% | +0.78% | -5.03% | -3.26% |
| Opening | US$7.240 | US$8.290 | US$7.730 | US$7.760 | US$7.570 |
| High | US$8.550 | US$8.390 | US$7.940 | US$7.830 | US$7.570 |
| Low | US$7.170 | US$7.410 | US$7.445 | US$7.260 | US$6.880 |
Performance
| 1 day | -3.26% | ||
| 1 week | -0.42% | ||
| Current month | -0.56% | ||
| 1 month | -36.73% | ||
| 3 months | -64.26% | ||
| 6 months | -59.81% | ||
| Current year | -60.74% | ||
| 1 year | -57.75% | ||
| 3 years | -66.99% | ||
| 5 years | -99.89% | ||
| 10 years | -99.95% |
Volumes
marketsDaily volume
3,133,757
Estimated daily volume
3,133,757
Avg. Volume 20 sessions
2,069,035
Daily volume ratio
1.51
Avg. Volume 20 sessions USD
14,752,219.55
Record volume 1
31,910,412
Record volume 2
26,189,975
Record volume 3
22,460,588
Capital turnover ratio
0.04
Float rotation
0.04
Basic data
Market Cap (USD)
426,156,121
Net sales (USD)
59,000
Number of employees
33
Sales / Employee (USD)
1,788
Free-Float
97.1%
Free-Float capitalization (USD)
413,818,874
Average Daily Capital Traded
3.46%
Indicators
Moving average 5 days
7.7
Moving average 20 days
7.972
Moving average 50 days
12.33
Moving average 100 days
15.6
Price spread / (MMA5)
+7.99%
Price spread / (MMA20)
+11.81%
Price spread / (MMA50)
+72.88%
Price spread / (MMA100)
+118.74%
STIM
RSI 9 days
44.57
RSI 14 days
38.26
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.26% | -0.42% | -57.75% | -66.99% | 426M | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 65.56B | ||
| -2.64% | -1.13% | +7.82% | +88.90% | 60.41B | ||
| -1.07% | +0.30% | +22.91% | +86.76% | 55.76B | ||
| +0.48% | -2.53% | +9.73% | +121.14% | 46.98B | ||
| -2.69% | -6.38% | +19.19% | +25.79% | 43.63B | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 36.7B | ||
| -2.50% | -15.73% | +135.31% | +662.73% | 36.09B | ||
| -0.77% | -2.21% | +77.27% | +57.96% | 32.9B | ||
| -0.83% | +1.98% | -38.27% | +390.98% | 26.96B | ||
| Average | -1.28% | -1.92% | +24.98% | +148.34% | 41B | |
| Weighted average by Cap. | -1.00% | -2.20% | +33.85% | +147.20% |
Historical Quotes: Avalo Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
1f971f1ba06c79aacfe0.89e76EHj3AzII1MhYjOLHbApCRU71hj4iMMLP4lQOug.vo3aoHXWhVOnVjFbDAK4b9xRcEwLpk6-5rpGWcAxArmBr4uBMK6be5lPHg
| Date | Price | Volume | Total |
|---|---|---|---|
| 21:00:00 | 7.130 | 208,607 | 2,784,456 |
| 20:59:59 | 7.140 | 100 | 2,575,849 |
| 20:59:59 | 7.150 | 100 | 2,575,749 |
| 20:59:59 | 7.140 | 200 | 2,575,649 |
| 20:59:59 | 7.140 | 300 | 2,575,449 |
| 20:59:59 | 7.140 | 700 | 2,575,149 |
| 20:59:59 | 7.130 | 700 | 2,574,449 |
| 20:59:59 | 7.130 | 100 | 2,573,749 |
| 20:59:59 | 7.130 | 326 | 2,573,649 |
| 20:59:59 | 7.130 | 100 | 2,573,323 |
Price Extremes
| 1 week | 6.88 | 8.39 | |
| 1 month | 6.53 | 13.18 | |
| Current year | 6.53 | 24.27 | |
| 1 year | 6.53 | 24.27 | |
| 3 years | 3.39 | 34.46 | |
| 5 years | 3.39 | 6,566.35 | |
| 10 years | 3.39 | 22,031.54 |
Monthly variations
Annual variations
| 2026 | -60.74% | ||
| 2025 | +144.41% | ||
| 2024 | -18.35% | ||
| 2023 | -99.25% | ||
| 2022 | -75.29% | ||
| 2021 | -35.61% | ||
| 2020 | -51.02% | ||
| 2019 | +66.87% | ||
| 2018 | +0.94% | ||
| 2017 | +263.47% | ||
| 2016 | -73.72% | ||
| 2015 | -16.25% |
- Stock Market
- Stocks
- AVTX Stock
- Quotes Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















